Jointace DN Tablet is a pharmaceutical formulation combining Glucosamine sulfate (750 mg), Diacerein (50 mg), and Methyl Sulfonyl Methane (MSM) (250 mg), designed to support joint health and alleviate symptoms associated with osteoarthritis and other degenerative joint disorders. Glucosamine is a naturally occurring amino sugar that plays a critical role in the biosynthesis of glycosaminoglycans, essential components of cartilage matrix, thereby promoting cartilage repair and maintenance. Diacerein, an anthraquinone derivative, exhibits anti-inflammatory and chondroprotective properties by inhibiting interleukin-1 beta, a key mediator in cartilage degradation and inflammation. Methyl Sulfonyl Methane is an organosulfur compound known for its antioxidant and anti-inflammatory effects, contributing to the reduction of joint pain and swelling while supporting connective tissue health. The synergistic action of these three active ingredients aids in improving joint mobility, reducing stiffness, and mitigating pain associated with osteoarthritis. Jointace DN Tablet is typically prescribed as part of a comprehensive management plan for patients experiencing mild to moderate joint discomfort, with dosing and duration tailored according to clinical response and physician guidance. It is important to use this medication under medical supervision to monitor efficacy and potential adverse effects.